Protein-ligand binding affinity is a key pharmacodynamic endpoint in drug discovery. Sole
reliance on experimental design, make, and test cycles is costly and time consuming …

Protein--ligand interaction (PLI) prediction is critical in drug discovery, aiding the
identification and enhancement of molecules that effectively bind to target proteins. Despite …

Drug design involves the process of identifying and designing molecules that bind well to a
given receptor. A vital computational component of this process is the protein–ligand …

Prediction of protein–ligand interactions (PLI) plays a crucial role in drug discovery as it
guides the identification and optimization of molecules that effectively bind to target proteins …

Data driven computational approaches to predicting protein–ligand binding are currently
achieving unprecedented levels of accuracy on held-out test datasets. Up until now …

One of the main challenges in drug discovery is predicting protein–ligand binding affinity.
Recently, machine learning approaches have made substantial progress on this task …

Predicting accurate protein–ligand binding affinities is an important task in drug discovery
but remains a challenge even with computationally expensive biophysics-based energy …

Accurately predicting protein–ligand binding affinities is an important problem in
computational chemistry since it can substantially accelerate drug discovery for virtual …

In the context of bioactivity prediction, the question of how to calibrate a score produced by a
machine learning method into a probability of binding to a protein target is not yet …

Modeling the interaction between proteins and ligands and accurately predicting their
binding structures is a critical yet challenging task in drug discovery. Recent advancements …